MEDEX GENIN
0895.403.040 · rovalta.com · 24/09/2026
NORMAL SITUATION
MEDEX GENIN
Company — Normal situation.
Financial year 2023 · Closed on 31/12/2023
Net result
115 k €
-13,1 %over 1 yearGross margin
256,6 k €
-10,5 %over 1 yearEquity
596,6 k €
+12,2 %over 1 yearOverview
Identity
Source · BCE/KBOMEDEX GENIN is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0895.403.040
- Legal form
- Private company with limited liability
- Contributed capital
- 12 500,00 €
- Latest accounts
- 31/12/2023
Joint committees (2)
- 200
- 330
Signals
ProfitableSolid equityGood liquidityPositive cashflowPositive EBITDAHealthy social debts
Financials
Source · NBB, 15 filingsTrend over 15 financial years
| 2023 | 2022 | 2021 | 2020 | 2019 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 256,6 k € | -10.5% | 286,8 k € | +28.1% | 223,8 k € | -8.2% | 243,8 k € | +13.6% | 214,6 k € |
| EBITDA | 199 k € | -11.8% | 225,8 k € | +33.0% | 169,8 k € | -10.6% | 189,9 k € | +19.8% | 158,5 k € |
| Operating result | 177 k € | -12.4% | 202,1 k € | +37.6% | 146,9 k € | -18.5% | 180,2 k € | +41.6% | 127,3 k € |
| Net result | 115 k € | -13.1% | 132,3 k € | -10.2% | 147,3 k € | +15.1% | 128 k € | +257% | 35,9 k € |
| Balance sheet | |||||||||
| Equity | 596,6 k € | +12.2% | 531,6 k € | +26.8% | 419,3 k € | +53.7% | 272,7 k € | +68.7% | 161,7 k € |
| Total assets | 626,7 k € | +15.3% | 543,6 k € | +26.0% | 431,5 k € | +41.0% | 306,1 k € | +32.2% | 231,5 k € |
| Cash | 460 k € | +27.2% | 361,8 k € | +71.8% | 210,5 k € | +56.9% | 134,2 k € | +71.0% | 78,5 k € |
| Debts | 30,1 k € | +151% | 12 k € | -1.5% | 12,2 k € | -63.4% | 33,3 k € | -52.2% | 69,8 k € |
| Other | |||||||||
| Workforce | – | – | – | – | – | ||||
Board of directors
Source · NBB, accounts to 31/12/20231 active · 3 ended
Active mandates
BERNARD GENIN
ActiveEnded mandates
BERNARD GENIN
EndedBernard GENIN
EndedBERNARD GENIN
EndedFinancials
Full financial information
Source · NBB| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 | 01/01/2019 | 01/01/2018 |
| Closing of the financial year | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 | 31/12/2019 | 31/12/2018 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 25/05/2024 | 28/05/2023 | 29/05/2022 | 30/05/2021 | 30/06/2020 | 07/05/2019 |
| General meeting | 24/05/2024 | 26/05/2023 | 27/05/2022 | 27/05/2021 | 28/05/2020 | 07/05/2019 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 15 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2023 | 24/05/2024 | 25/05/2024 | French | |
| Micro model | 31/12/2022 | 26/05/2023 | 28/05/2023 | French | |
| Micro model | 31/12/2021 | 27/05/2022 | 29/05/2022 | French | |
| Micro model | 31/12/2020 | 27/05/2021 | 30/05/2021 | French | |
| Micro model | 31/12/2019 | 28/05/2020 | 30/06/2020 | French | |
| Micro model | 31/12/2018 | 07/05/2019 | 07/05/2019 | French | |
| Abridged model | 31/12/2017 | 26/07/2018 | 30/07/2018 | French | |
| Abridged model | 31/12/2016 | 16/05/2017 | 02/06/2017 | French | |
| Abridged model | 31/12/2015 | 24/08/2016 | 29/08/2016 | French | |
| Abridged model | 31/12/2014 | 24/08/2015 | 25/08/2015 | French | |
| Abridged model | 31/12/2013 | 23/07/2014 | 04/08/2014 | French | |
| Abridged model | 31/12/2012 | 29/08/2013 | 29/08/2013 | French | |
| Abridged model | 31/12/2011 | 21/08/2012 | 27/08/2012 | French | |
| Abridged model | 31/12/2010 | 10/06/2011 | 01/08/2011 | French | |
| Abridged model | 31/12/2009 | 11/06/2010 | 17/07/2010 | French |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20231 active · 3 ended
Active mandates
BERNARD GENIN
ActiveEnded mandates
BERNARD GENIN
EndedBernard GENIN
EndedBERNARD GENIN
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Belgian Official Gazette publications
Source · Belgian Official Gazette- Dissolution27/01/2025RUBRIQUE FIN (CESSATION, ANNULATION CESSATION, NULLITE, CONC, REORGANISATION JUDICIAIRE, ETC...)
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2023Annual accounts 2023115 k €↓
- 2022Annual accounts 2022132,3 k €↓
- 2021Annual accounts 2021147,3 k €↑
- 2020Annual accounts 2020128 k €↑
- 2019Annual accounts 201935,9 k €↓
- 2018Annual accounts 201865,8 k €↑
- 2017Annual accounts 201755 k €↑
- 2016Annual accounts 2016-4,7 k €↓
- 2015Annual accounts 201555,1 k €↑
- 2014Annual accounts 20147,6 k €↓
- 2013Annual accounts 201391,7 k €↑
- 2012Annual accounts 201234,3 k €↑
- 2011Annual accounts 2011-34,5 k €↓
- 2010Annual accounts 2010-13,1 k €↓
- 2009Annual accounts 200930,9 k €